Lenalidomide in Combination with Arsenic Trioxide: an Effective Therapy for Primary Effusion Lymphoma

Lenalidomide in Combination with Arsenic Trioxide: an Effective Therapy for Primary Effusion Lymphoma

Primary effusion lymphoma (PEL) is a rare aggressive subset of non-Hodgkin B cell lymphoma. PEL is secondary to Kaposi sarcoma herpes virus (KSHV) and predominantly develops in serous cavities. Conventional chemotherapy remains the treatment of choice for PEL and yields high response rates with no s...

Full description

Bibliographic Details
Main Authors: Sara Moodad, Rana El Hajj, Rita Hleihel, Layal Hajjar, Nadim Tawil, Martin Karam, Maguy Hamie, Raghida Abou Merhi, Marwan El Sabban, Hiba El Hajj
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
HHV-8
immunomodulatory drugs
LANA
latent cycle
lytic cycle
lymphoma
Online Access:https://www.mdpi.com/2072-6694/12/9/2483

Internet

https://www.mdpi.com/2072-6694/12/9/2483

Similar Items